Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
32 USD | +1.78% | -0.79% | -22.24% |
May. 08 | Oppenheimer Adjusts Arvinas Price Target to $70 From $80, Maintains Outperform Rating | MT |
May. 07 | Arvinas Shares Up After Q1 Net Loss Narrows | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ARVINAS, INC. | Bio Therapeutic Drugs | +1.81% | -0.79% | -22.24% | +34.47% | +46.28% | 2.15B |
- Stock Market
- Equities
- ARVN Stock
- Charts Arvinas, Inc.
- Relative Strength Chart